Cadherins are important morphoregulatory molecules that are
involved in homophilic adhesion of cells. N-cadherin is a member of the
cadherin superfamily, which plays a crucial role in embryonic
morphogenesis, including muscle development. Previous studies indicated
that stable adhesive interactions must be established between
fusion-competent myoblasts, as a prerequisite for further
differentiation, and that these initial adhesions are calcium dependent
(
Knudsen et al., 1990 
). Specific involvement of N-cadherin
was also suggested on the basis of its high levels in prefusion
myoblasts (
MacCalman et al., 1992 
). Moreover, the
perturbation of N-cadherin–mediated adhesion in vitro affected the
rate (but not the final level) of myoblast fusion (
Mege et
al., 1992 
). It was suggested by other studies that N-cadherin may
not be essential for myotube formation, because specific blocking of
M-cadherin (a muscle-specific form) by inhibitory antibodies
blocks the fusion of cultured L6 myocytes (
Zeschingk et al.,
1995 
). In addition, myoblasts from N-cadherin–null mice are able to
fuse both in culture and in vivo (
Charlton et al., 1997 
). In
view of the complexity of the various systems discussed above, we have
attempted, in the present study, to examine the direct involvement of
N-cadherin in myogenesis by its clustering with specific ligands,
namely, NEC or anti-N-cadherin antibodies.
Here we present evidence that local clustering or immobilization of
N-cadherin triggers signaling events that activate the myogenic program
in several cultured myoblast lines. We found that the cadherin-reactive
beads activate and facilitate the myogenic program, including myotube
formation, expression of a variety of sarcomeric components, and
expression of the myogenic transcription factor myogenin.
Interestingly, myotube formation depends on high cell density even
after cadherin bead stimulation, whereas the expression of the
different muscle proteins, including myogenin, was also detected in
sparse cultures, apparently independently of cell fusion. This is in
line with the common sequence of myogenic events triggered by growth
factor withdrawal, which start with myogenin expression, induction of
growth arrest, expression of structural sarcomeric components, and,
finally, fusion into myotubes (
Andrés and Walsh, 1996 
). It is,
however, noteworthy that the growth arrest induced by
N-cadherin–reactive beads is not unique to the myogenic
differentiation pathway, and treatment of a variety of mesenchymal
cells with the same types of beads inhibits proliferation and blocks
the cell cycle at the G1 phase. The mechanism underlying this growth
inhibiting signaling process will be described in detail elsewhere
(
Levenberg et al., 1998b 
). Our data are consistent
with the notion that growth arrest precedes the expression of the
various structural sarcomeric components by ~24 h.
The crucial events in skeletal muscle differentiation are coordinated
by the expression of muscle regulatory proteins that act in cooperation
with the MEF2 family of transcription factors to activate
muscle-specific gene expression (
Yun and Wold, 1996 
). These proteins
were also shown to interact with and be regulated by other
transcription factors and the cell cycle regulatory system to
coordinately activate the differentiation program and to inhibit
proliferation (
Olson, 1992 
,
1993 
;
Rao et al., 1994 
;
Skapek
et al., 1995 
,
1996 
). The fine balance between proliferation
and differentiation appears to be critical for the induction and
progression of the myogenic program. For instance, in committed
myoblasts MyoD and Myf5 proteins are expressed, although their activity
is apparently inhibited by the presence of growth-promoting factors,
and thus the progression of differentiation depends on growth factor
withdrawal, leading to myogenin expression and activation of the
myogenic cascade (
Andrés and Walsh, 1996 
).
Numerous studies indicate that in the course of myogenic
differentiation inhibition of cell proliferation and cell death are
coordinately regulated, and the inability to exit the cell cycle leads
to apoptotic death (
Walsh and Perlman, 1997 
;
Fimia et al.,
1998 
). Cell cycle inhibitors, such as p21 or Rb, are able to prevent
this apoptosis most probably by the induction of cell cycle arrest
(
Wang and Walsh, 1996 
;
Wang et al., 1997 
;
Zacksenhaus
et al., 1996 
). As described above, treatment with
cadherin-reactive beads inhibits cell cycle progression in C2
myoblasts. However, no apparent differences in the number of apoptotic
nuclei (defined by DAPI staining) were observed after application of
the various beads (our unpublished results). Current reports
demonstrate that the decision to exit the cell cycle and further
differentiate or to die is made at the level of myogenin-induced cell
cycle arrest, i.e., at the stages of myogenesis when cells already
express myogenin. Because cadherin-reactive beads promote myogenin
expression, it seems to us unlikely that stimulation of
cadherin-mediated adhesion directly affects the apoptotic process.
Another aspect raised by the present study is the specificity of the
effects on myogenesis to N-cadherin. As indicated above, additional
members of the cadherin family are also expressed in muscle tissues,
including M- and R-cadherins (
Zeschingk et al., 1995 
;
Rosenberg et al., 1997 
) and cadherin-11 (
Kimura et
al., 1995 
), and perturbation of some of these can affect
myogenesis (
Zeschingk et al., 1995 
). We have no direct
evidence or claim that the effect shown here for N-cadherin stimulation
is unique to this isoform and cannot be obtained by the clustering or
immobilization of other cadherins. It is noteworthy that these three
cadherins show considerable overall homology with N-cadherin along
their cytoplasmic domains (82, 50, and 54% identity), which are
presumably involved in the transduction of N-cadherin–mediated
signals.
The data presented here are in agreement with the view that activation
of cadherin-mediated signaling leads to the expression of myogenin,
which in turn inhibits cell cycle progression, triggers the
differentiation program, including the expression of sarcomeric
proteins, and promotes myotube formation. The mechanism underlying this
cadherin-induced activation of myogenin expression is, however, not
clear. It was previously shown that cadherin-reactive beads
specifically activate tyrosine phosphorylation at adherens junctions
and enhance cadherin-mediated cell–cell adhesion in a variety of
mesenchymal cells (
Levenberg et al., 1998 
). This is
consistent with the present results, showing that cadherin-induced
stimulation leads to a specific and generalized enhancement of
myoblast–myoblast adhesion (Figure ). This, in turn, could have two
distinct effects that are highly relevant to the progression of
myogenic differentiation: 1) the signals triggered by the beads might
be directly involved in the stimulation of myogenin expression; and 2)
the apparent increase in cell adhesion, triggered by the beads, might
further promote the myogenin-induced progression of differentiation.
Another possible pathway for cadherin-induced effects might involve the
catenin system. β-Catenin, which is an intrinsic component of
adherens junctions, is also implicated in Wnt and Wg signaling (
Willert
and Nusse, 1998 
) and in malignant transformation (
Korinek et
al., 1997 
;
Morin et al., 1997 
;
Redfield et
al., 1997 
). In view of the capacity of extrajunctional β-catenin
to translocate to the nucleus and to be involved in gene
transactivation, together with LEF and Tcf transcription factors
(
Cavallo et al., 1997 
), it might be interesting to explore
the possibility that some of the genes whose expression is regulated
during myogenesis are under the control of β-catenin, and that
changes in β-catenin stability, localization, and/or activity might
affect the myogenic process. Some of these aspects are currently under
study.